Description
DECREASE EXCESS FUNDS FOR CLOSE OUT
Base award description: RADIOPHARMACEUTICALS
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2023-02-02+$1,964,353= $1,964,353
- Mod P000012024-02-06+$1,395,879= $3,360,233
- Mod P000022024-04-24-$883,243= $2,476,989
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2023-02-02 | +$1,964,353 | $1,964,353 | RADIOPHARMACEUTICALS |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-02-06 | +$1,395,879 | $3,360,233 | INCREASE FUNDING TO PAY INVOICE |
| Mod P00002· FUNDING ONLY ACTION | 2024-04-24 | −$883,243 | $2,476,989 | DECREASE EXCESS FUNDS FOR CLOSE OUT |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI JNM4NBNHFE66)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25526N0132 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $1,200,000 | FY2026 |
| 36C26026N0121 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $996,874 | FY2026 |
| 36C24926N0263 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $823,062 | FY2026 |
| 36C25525N0282 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $166,146 | FY2025 |
| 36C25525N0176 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $1,362,395 | FY2025 |
| 36C25225F0044 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $631,354 | FY2025 |
Other recipients under 6505 from 257-NETWORK CONTRACT OFFICE 17 (36C257) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25726N0367 | ISORX TEXAS LTD | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $53,945 | FY2026 |
| 36C25726N0407 | CARDINAL HEALTH 414, LLC | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $1,400,000 | FY2026 |
| 36C25726P0476 | PETNET SOLUTIONS, INC. | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $40,573 | FY2026 |
| 36C25726P0423 | PANHANDLE NUCLEAR RX, LTD. | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $325,038 | FY2026 |
| 36C25726N0316 | PROGENICS PHARMACEUTICALS INC | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $721,744 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25723N0156_3600_36F79719D0169_3600 · retrieved 2026-09-26.